These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7051482)

  • 1. Antibody response and allograft outcome with deliberate donor-specific blood transfusions.
    Mendez R; Iwaki Y; Mendez RG; Bogaard T; Self B; Konoeda Y; Terasaki PI
    Transplant Proc; 1982 Jun; 14(2):378-82. PubMed ID: 7051482
    [No Abstract]   [Full Text] [Related]  

  • 2. Serologic considerations in donor-specific transfusion therapy for kidney transplantation.
    Schweizer R; Bow L; Generas D; Bartus S
    Transplant Proc; 1982 Jun; 14(2):374-7. PubMed ID: 6810522
    [No Abstract]   [Full Text] [Related]  

  • 3. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
    Salvatierra O; Iwaki Y; Vincenti F; Amend W; Terasaki P; Garovoy M; Duca R; Hopper S; Feduska N
    Transplant Proc; 1982 Jun; 14(2):363-6. PubMed ID: 7051480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful renal transplantation after transient warm B cell antibody to donor-specific transfusions.
    Bow LM; Schweizer RT; Cho S
    Transplantation; 1984 Jun; 37(6):618-9. PubMed ID: 6203194
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of donor specific transfusion renal transplants across B cell positive crossmatches.
    Balakrishnan K; Munda R; First MR; Alexander JW
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1836. PubMed ID: 2652597
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved graft survival with donor-specific transfusion pretreatment.
    Cochrum K; Hanes D; Potter D; Perkins H; Amend W; Vincenti F; Iwaki Y; Opelz G; Terasaki P; Feduska N; Salvatierra O
    Transplant Proc; 1981 Mar; 13(1 Pt 1):190-3. PubMed ID: 7022820
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific anti-donor lymphocytotoxic antibodies following blood transfusion from nonrelated donors.
    Ettenger RB; Jordan SC; Arnett J; Robinson BJ; Fine RN
    Transplant Proc; 1982 Jun; 14(2):347-8. PubMed ID: 7051476
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of pretransplant donor-specific transfusions in renal transplantation.
    Leivestad T; Flatmark A; Hirschberg H; Thorsby E
    Transplant Proc; 1982 Jun; 14(2):370-3. PubMed ID: 6214064
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved graft survival following donor-specific blood transfusions.
    Cochrum K; Hanes D; Potter D; Perkins H; Amend W; Vincenti F; Iwaki Y; Opelz G; Terasaki P; Levin B; Sampson D; Feduska N; Salvatierra O
    Transplant Proc; 1981 Sep; 13(3):1657-61. PubMed ID: 7029829
    [No Abstract]   [Full Text] [Related]  

  • 10. Deliberate buffy-coat transfusions and the risk of antibody formation.
    Takahashi H; Iwaki Y; Terasaki PI; Okazaki H; Ishizaki M; Sekino H; Momma M; Takemoto S
    Transplant Proc; 1982 Jun; 14(2):349-54. PubMed ID: 7051477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
    Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
    Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant immunosuppression and donor-specific transfusions prior to renal transplantation.
    Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1828-31. PubMed ID: 2652594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytotoxic activity provoked by transfusion protocols.
    Fauchet R; Dunn JE; Campion JP; Lepogamp P; Genetet B; Launois B; Cartier F
    Transplant Proc; 1982 Jun; 14(2):355-8. PubMed ID: 7051478
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal allograft survival in CSA-treated patients with positive donor-specific B cell crossmatches.
    Noreen HJ; van der Hagen E; Bach FH; Najarian JS; Fryd DS
    Transplant Proc; 1989 Feb; 21(1 Pt 1):691-2. PubMed ID: 2650224
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of blood transfusion on the development of cytotoxic antibody and immunoregulatory lymphocyte subsets enumerated by monoclonal antibodies and FACS analysis.
    Guttmann RD; McIntyre C; Poulsen RS; Kirkwood K; Pshyk K; Jean R; Frei D
    Transplant Proc; 1982 Jun; 14(2):344-6. PubMed ID: 7051475
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA-DR matching and B-cell crossmatching in renal transplantation.
    Ting A; Williams KA; Morris PJ
    Transplant Proc; 1980 Sep; 12(3):495-501. PubMed ID: 7013181
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-idiotypic autoantibodies after donor-specific blood transfusions.
    Toma H; Hayasaka Y; Yasuo M; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1987 Feb; 19(1 Pt 1):755-7. PubMed ID: 3274864
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible mechanism of the beneficial effect of pretransplant blood transfusions on renal allograft survival in man.
    Singal DP; Joseph S; Szewczuk MR
    Transplant Proc; 1982 Jun; 14(2):316-8. PubMed ID: 6214059
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of dithiothreitol on a variety of evolutive patterns of anti-T and -B lymphocyte antibodies in renal transplant candidates.
    García de Masdevall MD; Arrieta A; Riñón M; Altés C; Arranz C
    Transplant Proc; 1992 Dec; 24(6):2505-7. PubMed ID: 1465847
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood transfusion and kidney transplantation: effect of small doses of blood on kidney graft function and survival.
    Sirchia G; Mercuriali F; Pizzi C; Rosso di San Secondo VE; Borzini P; Aniasi A
    Transplant Proc; 1982 Jun; 14(2):263-71. PubMed ID: 7051464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.